Skip to main content
. 2021 Feb 26;70(10):2795–2803. doi: 10.1007/s00262-021-02891-x

Fig. 5.

Fig. 5

Anti-CD133 CAR-T cells and cisplatin efficiently reduce tumor progression in KATO III and MKN-28 xenograft models. a Schematic representation of the time course of the experiment. Tumor volume of KATO III b and MKN-28 c subcutaneously injected mice. Data represent means ± SD. n = 5 mice. ***p < 0.001. A two-way ANOVA analysis with Tukey’s post hoc test was performed to evaluate the statistical significance